S 3180
116th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Marketing and advertising
Prescription drugs
Responsibility in Drug Advertising Act of 2020
Introduced: January 9, 2020
Introduced by:
King, Angus S., Jr.
Independent
· Maine
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 9, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 9, 2020
Introduced in Senate
Plain-English summary
Responsibility in Drug Advertising Act of 2020
This bill prohibits direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
What's happening now
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
1